---
title: Help patients express priorities clearly
nct_id: NCT04179695
phase: NA
status: RECRUITING
sponsor: University Hospital, Lille
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT04179695"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04179695"
last_fetched: "2026-05-10T14:07:16.316Z"
source: "Parkinson's Pathways (curated)"
---
# Help patients express priorities clearly

**Goal (in five words):** Help patients express priorities clearly

**Official Title:** Optimizing PD Patient's Health Pathways: Favoring Global, Patient Centered Care by a New Communication Aid Tool PARKINSUN

**Trial ID:** [NCT04179695](https://clinicaltrials.gov/study/NCT04179695)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University Hospital, Lille
- **Target Enrollment:** 120 participants
- **Start Date:** 2020-07-21
- **Completion Date:** 2026-12
- **Conditions:** Parkinson's Disease
- **Interventions:** Consulting with PARKINSUN as communication aid-tool, Consulting without PARKINSUN as communication aid-tool
- **Intervention Types:** OTHER

## Summary For Families

The goal is to make Parkinson's care more global and patient centered by improving how patients and clinicians talk about symptoms, priorities, and care plans during visits. The approach uses a communication aid called PARKINSUN during consultations, it prompts and structures patients' symptoms, concerns, and goals, creates a clear summary to help clinicians prioritize issues and guide shared decision making, and is compared to usual consultations without the tool. Adults 18 to 90 with Parkinson's at any stage who can consent and attend visits, have no severe other neurological or psychiatric disease, score above 22 on the MOCA, speak French, and have social security coverage are eligible; people under guardianship or unable to complete the study are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 90 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Adult men and women with all stages of PD
* Without severe chronic neurological or mental or psychiatric pathology
* Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
* able to come (alone or accompanied) to consultation
* Affiliate or beneficiary of a social security scheme
* Subject having signed informed consent
* Patient willing to comply with all procedures of the study and its duration

Exclusion Criteria:

* Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
* Subject under tutelage or curtailer.
* Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
```

## Locations (1)

- Hopital Roger Salengro, CHU Lille, Lille, France _(50.6339, 3.0551)_
  - (CONTACT) — 0320445962

## Central Contacts

- David Devos, MD,PhD — (CONTACT) — 03 20 44 54 49 — david.devos@chru-lille.fr

---

*Canonical: https://parkinsonspathways.com/trial/NCT04179695*  
*HTML version: https://parkinsonspathways.com/trial/NCT04179695*  
*Source data: https://clinicaltrials.gov/study/NCT04179695*